BJL
MRNA icon

Brighton Jones LLC’s Moderna MRNA Stock Holding History

Brighton Jones LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,042
Closed -$314K – 554
2023
Q1 		$314K Buy
2,042
+35
+2% +$5.77K 0.02% 367
2022
Q4 		$361K Sell
2,007
-41
-2% -$6.7K 0.02% 299
2022
Q3 		$242K Buy
2,048
+425
+26% +$64.5K 0.01% 374
2022
Q2 		$232K Sell
1,623
-233
-13% -$33.3K 0.01% 390
2022
Q1 		$320K Buy
1,856
+102
+6% +$17.2K 0.01% 353
2021
Q4 		$446K Buy
1,754
+29
+2% +$8.48K 0.02% 300
2021
Q3 		$664K Sell
1,725
-60
-3% -$22.1K 0.03% 215
2021
Q2 		$419K Buy
1,785
+73
+4% +$13K 0.02% 284
2021
Q1 		$224K Sell
1,712
-1,341
-44% -$194K 0.01% 376
2020
Q4 		$319K Buy
+3,053
New +$309K 0.02% 281
2020
Q3 		– Sell
-6,475
Closed -$416K – 343
2020
Q2 		$416K Buy
+6,475
New +$355K 0.03% 186

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brighton Jones LLC's MRNA Position: Q2 2023 in Review

Brighton Jones LLC sold out of Moderna (MRNA) in Q2 2023, closing a stake of 2,042 shares — an estimated $314K sold.

Brighton Jones LLC first reported a position in MRNA in Q2 2020 and held it in 11 quarters. The position peaked at $664K in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Brighton Jones LLC reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Brighton Jones LLC sold 2,042 Moderna shares in Q2 2023, an estimated $314K.
  • Brighton Jones LLC first reported a position in Moderna in Q2 2020 and held it in 11 quarters.
  • Brighton Jones LLC's Moderna position peaked at $664K in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Brighton Jones LLC's 13F filing for Q2 2023, filed 31 Jul 2023.